Showing 941 - 960 results of 102,495 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( 5 ((w decrease) OR (we decrease)) ))', query time: 1.70s Refine Results
  1. 941
  2. 942
  3. 943
  4. 944
  5. 945

    The effects of thioperamide and alpha-FMH on the amount of sleep/wake in WT and W/W<sup>v</sup> mice. by Sachiko Chikahisa (417256)

    Published 2013
    “…<p>(A) Injection of thioperamide (ip), a H3 antagonist, at a high dose (10 mg/kg) increased wakefulness in both WT and W/W<sup>v</sup> mice for 3 hours. …”
  6. 946
  7. 947
  8. 948
  9. 949
  10. 950
  11. 951
  12. 952
  13. 953
  14. 954

    All data points from Fig 5. by Sara Hijazi (21656615)

    Published 2025
    “…Specifically, we observed that demyelination caused an impairment in the ability of PV interneurons to sustain high-frequency firing associated with a substantial decrease in Kv3-specific currents. …”
  15. 955

    Decreased TNIP1 expression in SSc patients. by Yannick Allanore (58641)

    Published 2011
    “…<p>(A) Expression of the TNIP1 protein was decreased ex vivo in SSc lesional skin tissue compared to controls (arrows indicate TNIP-1 positive cells). …”
  16. 956

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
  17. 957
  18. 958
  19. 959
  20. 960

    Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

    Published 2012
    “…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”